These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3719191)

  • 1. Conservative treatment of early breast cancer.
    Ashraf J; Fentiman IS
    Br J Hosp Med; 1986 Apr; 35(4):263-5. PubMed ID: 3719191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interdisciplinary communication in breast-preserving therapy of early infiltrating ductal breast carcinoma].
    Greiner R; Kenesei G
    Schweiz Rundsch Med Prax; 1991 Mar; 80(11):262-8. PubMed ID: 1850870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of locally advanced breast cancer (stage III): a review.
    Davila E; Vogel CL
    Int Adv Surg Oncol; 1984; 7():297-327. PubMed ID: 6381318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence in the axilla after sentinel lymph node biopsy for breast cancer.
    Salmon RJ; Bouillet TH; Lewis JS; Clough KB
    Eur J Surg Oncol; 2002 Mar; 28(2):199. PubMed ID: 11884060
    [No Abstract]   [Full Text] [Related]  

  • 5. Results of conservative surgery for limited-sized infiltrating breast cancer: analysis of 962 tested patients: 24 years of experience.
    Vitucci C; Tirelli C; Graziano F; Santoro E
    J Surg Oncol; 2000 Jun; 74(2):108-15. PubMed ID: 10914819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast conservation surgery achieving>or=2 mm tumor-free margins results in decreased local-regional recurrence rates.
    Kunos C; Latson L; Overmoyer B; Silverman P; Shenk R; Kinsella T; Lyons J
    Breast J; 2006; 12(1):28-36. PubMed ID: 16409584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Incidence and treatment of local recurrences after conservative surgical treatment for cancer of the breast].
    Caravati F; Ginelli S; Riva M; Chiesa E; Calvi A
    J Chir (Paris); 1994 Nov; 131(11):505-10. PubMed ID: 7860691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing indications for surgery in patients with stage IV breast cancer: a current perspective.
    Morrogh M; Park A; Norton L; King TA
    Cancer; 2008 Apr; 112(7):1445-54. PubMed ID: 18306353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes in breast cancer patients with ten or more positive axillary nodes treated with combined-modality therapy: the importance of radiation field selection.
    Chang DT; Feigenberg SJ; Indelicato DJ; Morris CG; Lightsey J; Grobmyer SR; Copeland EM; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1043-51. PubMed ID: 17336214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up.
    Louis-Sylvestre C; Clough K; Asselain B; Vilcoq JR; Salmon RJ; Campana F; Fourquet A
    J Clin Oncol; 2004 Jan; 22(1):97-101. PubMed ID: 14701770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Options in the local management of invasive breast cancer.
    Nixon AJ; Troyan SL; Harris JR
    Semin Oncol; 1996 Aug; 23(4):453-63. PubMed ID: 8757272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node staging surgery and breast cancer: potholes in the fast lane from more to less.
    Moffat FL
    J Surg Oncol; 2005 Feb; 89(2):53-60. PubMed ID: 15660377
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Veronesi quadrantectomy: an established procedure for the conservative treatment of early breast cancer.
    Zurrida S; Costa A; Luini A; Galimberti V; Sacchini V; Intra M
    Int J Surg Investig; 2001; 2(6):423-31. PubMed ID: 12678123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future prospects in limited surgery for early breast cancer.
    Gazet JC
    Semin Surg Oncol; 1996; 12(1):39-45. PubMed ID: 8821408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of axillary recurrence after axillary lymph node dissection for invasive breast cancer.
    Voogd AC; de Boer R; van der Sangen MJ; Roumen RM; Rutten HJ; Coebergh JW
    Eur J Surg Oncol; 2001 Apr; 27(3):250-5. PubMed ID: 11373100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The criteria and place of limited surgery in treating breast cancer].
    Bălănescu I; Blidaru A; Duţu R
    Chirurgia (Bucur); 1991; 40(2):117-22. PubMed ID: 1688103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
    Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
    J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative margin status improves local control in conservatively managed breast cancer patients.
    Obedian E; Haffty BG
    Cancer J Sci Am; 2000; 6(1):28-33. PubMed ID: 10696736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.